These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 2843195)

  • 41. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of lisinopril in older patients with essential hypertension.
    Gomez HJ; Smith SG; Moncloa F
    Am J Med; 1988 Sep; 85(3B):35-7. PubMed ID: 2844085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
    Diamant M; Vincent HH
    J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
    Muller AF; Gardiner SM; Compton AM; Bennett T
    Clin Sci (Lond); 1990 Oct; 79(4):393-401. PubMed ID: 2171862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE inhibitors and cough.
    Yeşil S; Yeşil M; Bayata S; Postaci N
    Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
    Jessup M
    J Am Coll Cardiol; 1989 May; 13(6):1248-50. PubMed ID: 2539404
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of once-daily captopril or enalapril in mild essential hypertension.
    Pixley JS; Marshall MK; Stanley H; Starich GH; Ferguson RK
    J Clin Pharmacol; 1989 Feb; 29(2):118-22. PubMed ID: 2541177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
    Giles TD
    Z Kardiol; 1991; 80 Suppl 2():35-9. PubMed ID: 1850941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
    Herpin D; Conte D
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

  • 56. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.
    Gourlay S; McNeil J; Forbes A; McGrath B
    Clin Exp Hypertens; 1993 Jan; 15(1):71-89. PubMed ID: 8385525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.
    Pool JL; Nelson EB; Taylor AA
    Am J Med; 1988 Sep; 85(3B):19-24. PubMed ID: 2844082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.